
    
      This is the long-term follow-up study (ZOE-LTFU) of studies 110390 and 113077
      (ZOSTER-006/022) to assess the prophylactic efficacy, safety, and immunogenicity persistence
      of GSK Biologicals' Herpes Zoster subunit (HZ/su) vaccine and will include an assessment of 1
      or 2 additional doses on a 0 or 0, 2-month schedule in two subgroups of older adults.
    
  